Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2026-03-09 @ 11:35 PM
Study NCT ID:
NCT00476112
Status:
COMPLETED
Last Update Posted:
2008-04-02
First Post:
2007-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter
Sponsor:
Advanz Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1235-0703B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Sheila Grant, VP of Product Development, Vernakalant
Old Organization:
Cardiome Pharma Corp.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |